| P2093 | author name string | Joan Prudic | |
| | Nancy A Payne | |
| P2860 | cites work | A Seven-Month Double-Blind Trial of Amitriptyline and Diazepam in ECT-Treated Depressed Patients | Q22255572 |
| | Development of a Rating Scale for Primary Depressive Illness | Q29616244 |
| | Use of ECT in California, revisited: 1984-1994. | Q33805325 |
| | Relapse of depression after ECT: a review. | Q33874086 |
| | The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy | Q33874098 |
| | Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence | Q33974684 |
| | A Statistical Review of Controlled Trials of Imipramine and Placebo in the Treatment of Depressive Illnesses | Q34065255 |
| | The Practice of ECT: Recommendations for Treatment, Training and Privileging | Q34098407 |
| | Personality pathology in recurrent depression: nature, prevalence, and relationship to treatment response | Q34175472 |
| | Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder? | Q34288714 |
| | Effectiveness of electroconvulsive therapy in community settings | Q34292633 |
| | Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial | Q34514200 |
| | The cognitive effects of electroconvulsive therapy in community settings | Q34561037 |
| | Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE) | Q34587351 |
| | Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. | Q34589017 |
| | Electroconvulsive therapy: attitudes and misconceptions | Q36133070 |
| | Relapse after recovery from unipolar depression: a critical review | Q39515705 |
| | Psychosocial functioning and depression: distinguishing among antecedents, concomitants, and consequences | Q39515711 |
| | Continuation therapy following ECT: directions for future research | Q40605106 |
| | Patients' fear of and objection to electroconvulsive therapy | Q40891915 |
| | A review of continuation and maintenance electroconvulsive therapy | Q41529223 |
| | The importance of Axis II in patients with major depression. A controlled study | Q41850168 |
| | Major depressive disorder and borderline personality disorder revisited: longitudinal interactions | Q43915652 |
| | Preoperative anxiety. Its affect on cognitive thinking | Q44321104 |
| | Informing Patients About Electroconvulsive Therapy: Effects of a Videotape Presentation. | Q46015381 |
| | Psychiatry Resident and Medical Student Perspectives on ECT: Influence of Exposure and Education. | Q46775023 |
| | Relatives and depressive relapse: the critical period after discharge from in-patient treatment. | Q51164869 |
| | Structuring and anxiety reduction prior to myelography. | Q51167572 |
| | Preoperative teaching helps reduce anxiety. | Q51177574 |
| | Levels of expressed emotion and relapse in depressed patients. | Q51210754 |
| | Subjective Side-Effects of ECT | Q51296474 |
| | An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. | Q51351615 |
| | Electroconvulsive Treatment in Great Britain | Q51864487 |
| | Medical student knowledge and attitudes regarding ECT prior to and after viewing ECT scenes from movies. | Q51958448 |
| | The portrayal of ECT in American movies. | Q51961704 |
| | ECT: an assessment of mental health professionals' knowledge and attitudes. | Q52082545 |
| | Medical, judicial, and statutory regulation of ECT in the United States. | Q52091105 |
| | Are Patients Shocked by ECT? | Q52101861 |
| | A survey of attitudes on the use of electroconvulsive therapy. | Q52102146 |
| | ECT: I. Patients' experiences and attitudes. | Q52229204 |
| | History, power, and electricity: American popular magazine accounts of electroconvulsive therapy, 1940-2005. | Q53161638 |
| | The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem. | Q53294838 |
| | The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. | Q54326619 |
| | Medication resistance and clinical response to electroconvulsive therapy. | Q54329990 |
| | Autonomy and beneficence: ethical issues in electroconvulsive therapy | Q58682498 |
| | ECT response in depressed patients with and without a DSM-III personality disorder | Q60447153 |
| | Effect of Two Educational Interventions on Knowledge and Attitudes Towards Electroconvulsive Therapy | Q60631175 |
| | The implications of DSM-III personality disorders for patients with major depression | Q60639005 |
| | Recovery and major depression: factors associated with twelve-month outcome | Q61010189 |
| | Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program | Q68794507 |
| | Clinical predictors of recurrence in depression | Q69624109 |
| | NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel | Q70067782 |
| | Electroconvulsive therapy patient/family education | Q70804419 |
| | Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia | Q71465922 |
| | Role of the family in recovery and major depression | Q72340514 |
| | Poor response to electroconvulsive therapy in patients with a combined diagnosis of major depression and borderline personality disorder | Q72537634 |
| | Patient attitudes toward electroconvulsive therapy | Q72598534 |
| | Marital dissatisfaction and incidence of major depressive episode in a community sample | Q73298805 |
| | Personality and personality disorders predict development and relapses of major depression | Q73338735 |
| | The stigma and the enigma of ECT | Q77783926 |
| | Patients' Views on Electroconvulsive Therapy on Completion of a Course of Treatment | Q77901573 |
| | Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial | Q82979909 |
| P433 | issue | 5 | |
| P304 | page(s) | 369-390 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Journal of Psychiatric Practice | Q15749904 |
| P1476 | title | Electroconvulsive therapy: Part II: a biopsychosocial perspective | |
| P478 | volume | 15 | |